Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

More On BLRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials


BioLineRx, Ltd. (BLRX)

-NasdaqCM

1.67 Down 0.08(4.57%) 3:58PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue -   -   31,953  
Cost of Revenue -   -  7,220  
Gross Profit -   -   24,732  
Operating Expenses
Research Development17,235  11,147  15,521  
Selling General and Administrative4,624  4,192  5,502  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (21,859) (15,339) 3,710  
Income from Continuing Operations
Total Other Income/Expenses Net3,425  3,329  863  
Earnings Before Interest And Taxes(18,435)(12,010)4,573  
Interest Expense2,007  1,115  2,472  
Income Before Tax(20,442)(13,125)2,101  
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(20,442)(13,125)2,101  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (20,442) (13,125) 2,101  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (20,442) (13,125) 2,101  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.